Literature DB >> 7681015

The fidelity of the reverse transcriptases of human immunodeficiency viruses and murine leukemia virus, exhibited by the mispair extension frequencies, is sequence dependent and enzyme related.

M Bakhanashvili1, A Hizi.   

Abstract

Sequence variations in HIV-1 and HIV-2 probably result in part from inaccurate DNA synthesis by viral reverse transcriptases (RTs). We have studied in vitro the fidelity of both the DNA- and RNA-dependent DNA polymerization functions of the two HIV RTs, as compared to that of murine leukemia virus (MLV) RT. The two HIV RTs were less accurate than MLV RT. The mispair extension frequencies observed previously with ribosomal RNA (rRNA) template were higher than those detected with phi X174am3 DNA template with all three RTs. In the current study we have investigated whether the nature of the copied nucleic acid (RNA vs. DNA) or the template nucleotide sequences affect the accuracy of DNA synthesis. We have analyzed the fidelity of DNA synthesis with DNA sequences identical to those of the rRNA sequences previously employed for reverse transcription. The results indicate that the fidelity of DNA synthesis depends mainly on the nucleotide sequences copied by every given RT. Yet, fidelity of DNA synthesis depends not only on the sequences copied but also on the nature of the enzymes per se. It is possible that these factors are major contributors to the high mutation rates of the two human immunodeficiency viruses.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7681015     DOI: 10.1016/0014-5793(93)80067-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  17 in total

1.  High rate of mismatch extension during reverse transcription in a single round of retrovirus replication.

Authors:  G A Pulsinelli; H M Temin
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

Review 2.  Mechanisms of nucleoside analog antiviral activity and resistance during human immunodeficiency virus reverse transcription.

Authors:  E J Arts; M A Wainberg
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

Review 3.  Retroviral reverse transcriptases.

Authors:  Alon Herschhorn; Amnon Hizi
Journal:  Cell Mol Life Sci       Date:  2010-04-01       Impact factor: 9.261

4.  Intrinsic DNA synthesis fidelity of xenotropic murine leukemia virus-related virus reverse transcriptase.

Authors:  Verónica Barrioluengo; Yi Wang; Stuart F J Le Grice; Luis Menéndez-Arias
Journal:  FEBS J       Date:  2012-03-16       Impact factor: 5.542

5.  Mode of inhibition of HIV reverse transcriptase by 2-hexaprenylhydroquinone, a novel general inhibitor of RNA-and DNA-directed DNA polymerases.

Authors:  S Loya; A Rudi; Y Kashman; A Hizi
Journal:  Biochem J       Date:  1997-06-15       Impact factor: 3.857

6.  Host-specific modulation of the selective constraints driving human immunodeficiency virus type 1 env gene evolution.

Authors:  P Bagnarelli; F Mazzola; S Menzo; M Montroni; L Butini; M Clementi
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

7.  The processivity of DNA synthesis exhibited by drug-resistant variants of human immunodeficiency virus type-1 reverse transcriptase.

Authors:  O Avidan; A Hizi
Journal:  Nucleic Acids Res       Date:  1998-04-01       Impact factor: 16.971

8.  Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase.

Authors:  L M Mansky; H M Temin
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

9.  Snipping polymorphisms from large EST collections in barley (Hordeum vulgare L.).

Authors:  R Kota; S Rudd; A Facius; G Kolesov; T Thiel; H Zhang; N Stein; K Mayer; A Graner
Journal:  Mol Genet Genomics       Date:  2003-08-23       Impact factor: 3.291

10.  The role of phenylalanine-119 of the reverse transcriptase of mouse mammary tumour virus in DNA synthesis, ribose selection and drug resistance.

Authors:  Michal Entin-Meer; Ziv Sevilya; Amnon Hizi
Journal:  Biochem J       Date:  2002-10-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.